BA
BlackRock Advisors’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | $411M | Buy |
1,448,464
+257,964
| +22% | +$73.2M | 0.42% | 48 |
|
2016
Q3 | $373M | Buy |
1,190,500
+128,533
| +12% | +$40.2M | 0.38% | 58 |
|
2016
Q2 | $257M | Sell |
1,061,967
-8,080
| -0.8% | -$1.95M | 0.26% | 90 |
|
2016
Q1 | $279M | Sell |
1,070,047
-286,524
| -21% | -$74.6M | 0.29% | 80 |
|
2015
Q4 | $416M | Sell |
1,356,571
-202,049
| -13% | -$61.9M | 0.44% | 54 |
|
2015
Q3 | $455M | Buy |
1,558,620
+755,770
| +94% | +$221M | 0.49% | 40 |
|
2015
Q2 | $324M | Buy |
802,850
+77,722
| +11% | +$31.4M | 0.34% | 79 |
|
2015
Q1 | $306M | Sell |
725,128
-55,059
| -7% | -$23.2M | 0.31% | 82 |
|
2014
Q4 | $265M | Sell |
780,187
-745,660
| -49% | -$253M | 0.27% | 95 |
|
2014
Q3 | $505M | Sell |
1,525,847
-274,019
| -15% | -$90.6M | 0.5% | 43 |
|
2014
Q2 | $568M | Buy |
1,799,866
+339,384
| +23% | +$107M | 0.54% | 37 |
|
2014
Q1 | $447M | Buy |
1,460,482
+468,965
| +47% | +$143M | 0.44% | 51 |
|
2013
Q4 | $277M | Buy |
991,517
+11,411
| +1% | +$3.19M | 0.27% | 91 |
|
2013
Q3 | $236M | Buy |
980,106
+155,331
| +19% | +$37.4M | 0.24% | 106 |
|
2013
Q2 | $177M | Buy |
+824,775
| New | +$177M | 0.19% | 128 |
|